Stay updated on Cevostamab Safety & Activity in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Cevostamab Safety & Activity in Multiple Myeloma Clinical Trial page.

Latest updates to the Cevostamab Safety & Activity in Multiple Myeloma Clinical Trial page
- CheckyesterdayChange DetectedThe new screenshot shows an updated version of the record with changes to the study status and recruitment details for CAMMA 1 (NCT04910568). The layout remains similar, but the updated entries reflect progress in the trial.SummaryDifference0.1%

 - Check8 days agoNo Change Detected
 - Check23 days agoChange DetectedUpdate adds a new study status section with contacts/locations and a new date entry, while removing an older dated item to reflect current information.SummaryDifference0.7%

 - Check30 days agoChange Detected- Added a government funding notice and operating status guidance, plus a pointer to cc.nih.gov; - Bumped version from v3.1.0 to v3.2.0.SummaryDifference9%

 - Check37 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.2%

 - Check51 days agoChange DetectedThe page now shows Revision: v3.0.2, replacing v3.0.1 to indicate a new release. The 'Back to Top' label was removed as a minor UI cleanup.SummaryDifference0.6%

 - Check59 days agoChange DetectedThe web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content.SummaryDifference0.6%

 
Stay in the know with updates to Cevostamab Safety & Activity in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cevostamab Safety & Activity in Multiple Myeloma Clinical Trial page.